By Maggie FickLONDON (Reuters) -Novo Nordisk on Wednesday trimmed its full-year income outlook after reporting weaker-than-expected quarterly product sales of its widespread weight-loss drug Wegovy, stirring worries amongst patrons about stiffening rivals from...